null

SMILES: NC(=O)c1c2CN(CCn2nc1-c1cccc(F)c1)C(=O)NC1C2CC3CC(C2)CC1C3

InChI Key: InChIKey=APIRGJGOGFJRJH-UHFFFAOYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 302453   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Casein kinase I isoform delta (Homo sapiens (Human))	BDBM302453 (N5-(Adamantan-2-yl)-2- (3-fluorophenyl)-6,7- dihyd...) Show SMILES NC(=O)c1c2CN(CCn2nc1-c1cccc(F)c1)C(=O)NC1C2CC3CC(C2)CC1C3 |TLB:28:23:31:26.27.29,28:27:22.23.24:31,THB:21:22:31:26.27.29,26:25:22:28.27.29,26:27:22:24.25.31,(-2.46,1.95,;-1.37,3.04,;-1.77,4.52,;.12,2.64,;.59,1.17,;-.18,-.16,;.59,-1.49,;2.13,-1.49,;2.9,-.16,;2.13,1.17,;2.61,2.64,;1.36,3.54,;1.36,5.08,;.03,5.85,;.03,7.39,;1.36,8.16,;2.7,7.39,;4.03,8.16,;2.7,5.85,;-.18,-2.83,;-1.72,-2.83,;.59,-4.16,;-.18,-5.5,;-1.72,-5.5,;-2.49,-6.83,;-1.72,-8.16,;-3.26,-8.16,;-4.03,-6.83,;-3.26,-5.5,;-.74,-7.6,;.59,-6.83,;-.18,-8.16,)| Show InChI InChI=1S/C24H28FN5O2/c25-18-3-1-2-15(11-18)22-20(23(26)31)19-12-29(4-5-30(19)28-22)24(32)27-21-16-7-13-6-14(9-16)10-17(21)8-13/h1-3,11,13-14,16-17,21H,4-10,12H2,(H2,26,31)(H,27,32)	PDB UniProtKB/SwissProt B.MOAD GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...				US Patent US9598423 (2017) BindingDB Entry DOI: 10.7270/Q2FJ2JT9
					More data for this Ligand-Target Pair
Casein kinase I isoform epsilon (Homo sapiens (Human))	BDBM302453 (N5-(Adamantan-2-yl)-2- (3-fluorophenyl)-6,7- dihyd...) Show SMILES NC(=O)c1c2CN(CCn2nc1-c1cccc(F)c1)C(=O)NC1C2CC3CC(C2)CC1C3 |TLB:28:23:31:26.27.29,28:27:22.23.24:31,THB:21:22:31:26.27.29,26:25:22:28.27.29,26:27:22:24.25.31,(-2.46,1.95,;-1.37,3.04,;-1.77,4.52,;.12,2.64,;.59,1.17,;-.18,-.16,;.59,-1.49,;2.13,-1.49,;2.9,-.16,;2.13,1.17,;2.61,2.64,;1.36,3.54,;1.36,5.08,;.03,5.85,;.03,7.39,;1.36,8.16,;2.7,7.39,;4.03,8.16,;2.7,5.85,;-.18,-2.83,;-1.72,-2.83,;.59,-4.16,;-.18,-5.5,;-1.72,-5.5,;-2.49,-6.83,;-1.72,-8.16,;-3.26,-8.16,;-4.03,-6.83,;-3.26,-5.5,;-.74,-7.6,;.59,-6.83,;-.18,-8.16,)| Show InChI InChI=1S/C24H28FN5O2/c25-18-3-1-2-15(11-18)22-20(23(26)31)19-12-29(4-5-30(19)28-22)24(32)27-21-16-7-13-6-14(9-16)10-17(21)8-13/h1-3,11,13-14,16-17,21H,4-10,12H2,(H2,26,31)(H,27,32)	PDB KEGG UniProtKB/SwissProt B.MOAD antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	<10	n/a	n/a	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description The kinase assay was performed in V-bottom 384-well plates. The final assay volume was 30 μl prepared from 15 μl additions of enzyme, subst...				US Patent US9598423 (2017) BindingDB Entry DOI: 10.7270/Q2FJ2JT9
					More data for this Ligand-Target Pair